Literature DB >> 33421442

An Update on Evaluation and Management in Cystinuria.

Sunil Daga1, Victor Palit2, James A Forster3, Chandra Shekhar Biyani4, Adrian D Joyce2, Antonia Borissova Dimitrova5.   

Abstract

Cystinuria is the most common cause of inherited stone disease and is caused by the failure of absorption of filtered dibasic amino acids including cystine in the proximal tubules. It is associated with a very high recurrence rate in affected patients, with the potential for significant morbidity in such patients due to the need for repeated surgical interventions. A multimodal and multispecialty approach in a dedicated centre is the key to improving treatment outcomes and patient adherence to the treatment. This article reviews the latest knowledge on the clinical and diagnostic features and summarises key developments to aid clinicians in diagnosis and management options, together with future directions for the care of these patients. Crown
Copyright © 2021. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33421442     DOI: 10.1016/j.urology.2020.12.025

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  3 in total

1.  Accurate 24-h urine cystine quantification for patients on cystine-binding thiol drugs.

Authors:  Charles C Mikel; David S Goldfarb; Amy Ponte; Katherine Steigelman; Sergey Latyshev
Journal:  Urolithiasis       Date:  2022-10-06       Impact factor: 2.861

2.  Attitudes of urologists on metabolic evaluation for urolithiasis: outcomes of a global survey from 57 countries.

Authors:  Mehmet Ali Karagöz; Selçuk Güven; Tzevat Tefik; Mehmet İlker Gökçe; Murat Can Kiremit; Feyzi Arda Atar; Muhammed Arif İbiş; Yasin Yitgin; Abubekir Böyük; Samed Verep; Kemal Sarıca
Journal:  Urolithiasis       Date:  2022-09-28       Impact factor: 2.861

Review 3.  Cystinuria: Review of a Life-long and Frustrating Disease.

Authors:  Nicholas S Kowalczyk; Anna L Zisman
Journal:  Yale J Biol Med       Date:  2021-12-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.